Krystal Biotech (NASDAQ: KRYS) revenue
Krystal Biotech reported revenue of $389.1m for fiscal 2025, 33.9% more than in fiscal 2024 ($290.5m).
Krystal Biotech has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 5 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $389.1m | +33.9% | $161.3m | 41.5% |
| 2024 | $290.5m | +473.0% | $65.7m | 22.6% |
| 2023 | $50.7m | — | −$109.6m | −216.2% |
| 2022 | $0.0m | — | −$145.2m | — |
| 2021 | $0.0m | — | −$68.3m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Krystal Biotech revenue compared with its sector
By revenue for its latest fiscal year, Krystal Biotech ranks 206th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Krystal Biotech, 33.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 204th | Ardelyx | $407.3m | 22.1% |
| 205th | Immunocore | $400.0m | 29.0% |
| 206th | Krystal Biotech | $389.1m | 33.9% |
| 207th | Sonida Senior Living | $381.1m | 25.2% |
| 208th | CareDx | $379.8m | 13.8% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Krystal Biotech
- How much revenue did Krystal Biotech make in fiscal 2025?
- Krystal Biotech reported revenue of $389.1m for fiscal 2025, compared with $290.5m in fiscal 2024.
- What was the best year for revenue at Krystal Biotech?
- Of its last 5 fiscal years, fiscal 2025, with $389.1m.
- Where does Krystal Biotech rank in its sector by revenue?
- It ranks 206th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Krystal Biotech come from?
- From the annual report (Form 10-K) that Krystal Biotech files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Krystal Biotech files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Krystal Biotech: the Krystal Biotech page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.